Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3869 | YDES YD Bio Limited - Ordinary Shares | 2.00 USD | 0.00% | -17.36% | -32.20% | -75.00% | 141.58 M USD | ||
| 3874 | CBUS Cibus, Inc. - Class A Common Stock | 1.76 USD | +17.33% | +24.82% | +43.09% | +10.00% | 134.34 M USD | ||
| 3885 | CUE Cue Biopharma, Inc. - Common Stock | 32.66 USD | -2.19% | +11.66% | +11.20% | +4313.51% | 132.13 M USD | ||
| 3891 | ENGN enGene Therapeutics Inc. - Common Stock | 1.85 USD | -3.65% | +4.52% | +10.78% | -77.98% | 123.93 M USD | ||
| 3894 | GNLX Genelux Corporation - Common Stock | 2.87 USD | -3.37% | -0.35% | -4.01% | -17.77% | 128.69 M USD | ||
| 3895 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 2.13 USD | -4.48% | -9.75% | +21.02% | -51.59% | 128.48 M USD | ||
| 3900 | COYA Coya Therapeutics, Inc. - Common Stock | 5.38 USD | -6.43% | -8.03% | +15.95% | -12.66% | 126.20 M USD | ||
| 3903 | VANI Vivani Medical, Inc. - Common Stock | 1.50 USD | +11.11% | +22.95% | +30.43% | +18.11% | 129.35 M USD | ||
| 3909 | GUTS Fractyl Health, Inc. - Common Stock | 0.78 USD | -2.50% | -2.50% | +16.42% | -48.68% | 123.75 M USD | ||
| 3911 | SPRO Spero Therapeutics, Inc. - Common Stock | 2.13 USD | -1.39% | -5.33% | -23.38% | -28.28% | 123.33 M USD | ||
| 3915 | PMN ProMIS Neurosciences Inc. - Common Shares | 13.65 USD | +0.74% | +0.59% | +35.82% | +3312.50% | 122.41 M USD | ||
| 3928 | SEER Seer, Inc. - Class A Common Stock | 2.16 USD | -2.70% | +31.71% | +20.67% | -0.92% | 118.76 M USD | ||
| 3938 | AARD Aardvark Therapeutics, Inc. - Common Stock | 5.09 USD | -6.43% | -6.26% | +42.18% | -59.64% | 111.05 M USD | ||
| 3944 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.53 USD | -6.21% | +0.67% | +6.34% | -55.72% | 107.78 M USD | ||
| 3951 | NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.31 USD | -0.92% | -1.60% | -5.27% | -50.86% | 112.12 M USD | ||
| 3953 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 6.35 USD | +4.61% | +7.26% | +5.31% | +5.48% | 109.09 M USD | ||
| 3961 | BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.91 USD | -8.17% | -1.04% | +1.06% | -23.60% | 109.45 M USD | ||
| 3983 | ENLV Enlivex Ltd. - Ordinary Shares | 0.44 USD | -10.20% | -20.00% | -38.89% | -63.33% | 104.45 M USD | ||
| 3988 | ANIX Anixa Biosciences, Inc. - Common Stock | 3.12 USD | +5.41% | +6.85% | +26.83% | -0.64% | 106.15 M USD | ||
| 3994 | ONCY Oncolytics Biotech Inc. - Common Stock | 0.82 USD | -4.65% | -9.89% | -3.53% | -36.92% | 97.87 M USD |
Notícias Biotechnology Stocks
BofA mantém recomendação de compra para Beam Therapeutics após decisão arbitral
Dinamarca - Ações fecharam o pregão em queda e o Índice OMX Copenhagen 20 recuou 1,33%
‘Por que a CVM não viu isso antes?’
Por que as ações da Beam Therapeutics estão caindo hoje?
Por que as ações da Prime Medicine estão disparando hoje?
Ação da Incyte atinge máxima de 52 semanas em US$ 118,77
Ações da Prime Medicine disparam após vitória em arbitragem contra a Beam
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
VANI Vivani Medical, Inc. - Common Stock | 1.50 | +11.11% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
CCCC C4 Therapeutics, Inc. - Common Stock | 3.81 | -12.41% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |